MCRB - SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Seres Therapeutics Inc. (NASDAQ: MCRB) and Encourages Investors to Contact the Firm | Benzinga
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Seres Therapeutics, Inc. (NASDAQ:MCRB) ("Seres") on behalf of the company's investors.
Since June 2023, shares of Seres' common stock have declined in value from a trading price of over $5.00 per share to a current trading price of less than $1.00 per share, a cumulative decline of 80% in ...
MCRB) and Encourages Investors to Contact the Firm>Full story available on Benzinga.com